Ayrshire Capital Management LLC Amgen Inc Transaction History

Ayrshire Capital Management LLC

$200 Million
Q3 2024

A detailed history of Ayrshire Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Ayrshire Capital Management LLC holds 3,893 shares of AMGN stock, worth $1.02 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

3,893

Previous 3,836 1.49%

Holding current value

$1.02 Million

Previous $1.2 Million 4.67%

% of portfolio

0.63%

Previous 0.64%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$309.38 - $337.38 $17,634 - $19,230	57 Added 1.49%	3,893 $1.25 Million
Q2 2024 Jul 22, 2024	BUY	$262.75 - $319.31 $26,275 - $31,931	100 Added 2.68%	3,836 $1.2 Million
Q1 2024 Apr 17, 2024	BUY	$268.87 - $324.56 $51,085 - $61,666	190 Added 5.36%	3,736 $1.06 Million
Q4 2023 Jan 09, 2024	BUY	$255.7 - $288.46 $15,853 - $17,884	62 Added 1.78%	3,546 $1.02 Million
Q3 2023 Oct 12, 2023	SELL	$218.65 - $271.46 $437 - $542	-2 Reduced 0.06%	3,484 $936,000
Q2 2023 Jul 14, 2023	BUY	$214.27 - $253.37 $28,712 - $33,951	134 Added 4.0%	3,486 $773,000
Q1 2023 Apr 13, 2023	SELL	$225.79 - $275.2 $451 - $550	-2 Reduced 0.06%	3,352 $810,000
Q4 2022 Jan 11, 2023	BUY	$229.03 - $291.01 $15,345 - $19,497	67 Added 2.04%	3,354 $0
Q3 2022 Oct 11, 2022	BUY	$224.46 - $253.15 $53,645 - $60,502	239 Added 7.84%	3,287 $741,000
Q2 2022 Jul 08, 2022	SELL	$230.71 - $256.74 $70,597 - $78,562	-306 Reduced 9.12%	3,048 $741,000
Q1 2022 Apr 19, 2022	BUY	$219.27 - $242.57 $83,322 - $92,176	380 Added 12.78%	3,354 $811,000
Q4 2021 Jan 12, 2022	BUY	$198.88 - $227.6 $5,369 - $6,145	27 Added 0.92%	2,974 $669,000
Q3 2021 Oct 12, 2021	BUY	$212.27 - $248.7 $19,104 - $22,383	90 Added 3.15%	2,947 $627,000
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $17,518 - $19,435	75 Added 2.7%	2,857 $696,000
Q1 2021 May 11, 2021	BUY	$221.91 - $258.6 $1,997 - $2,327	9 Added 0.32%	2,782 $692,000
Q4 2020 Jan 21, 2021	BUY	$216.38 - $257.67 $130,044 - $154,859	601 Added 27.67%	2,773 $638,000
Q3 2020 Oct 20, 2020	BUY	$234.65 - $260.95 $78,373 - $87,157	334 Added 18.17%	2,172 $552,000
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $189,106 - $232,059	-956 Reduced 34.22%	1,838 $433,000
Q1 2020 Apr 17, 2020	BUY	$182.24 - $241.7 $54,125 - $71,784	297 Added 11.89%	2,794 $567,000
Q4 2019 Jan 30, 2020	BUY	$189.21 - $243.2 $472,457 - $607,270	2,497 New	2,497 $602,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ayrshire Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ayrshire Capital Management LLC with notifications on news.

Account

Ayrshire Capital Management LLC Amgen Inc Transaction History